ALPHA 1 BIOMEDICALS PLANS PHASE III THYMOSIN ALPHA 1 TRIALS IN RECENTLY ADOPTED PLAN; GOVERNOR’s VETO OF BILL OVERRIDDEN BY LEGISLATURE MAY 22

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".